Chun HG - Search Results

1

Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy.

Arlin ZA, Ahmed T, Mittelman A, Cook P, Puccio CA, Helson L, Chun HG. Arlin ZA, et al. Among authors: chun hg. Int J Clin Lab Res. 1992;21(4):273-7. doi: 10.1007/BF02591660. Int J Clin Lab Res. 1992. PMID: 1591379 Review.

2

"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment.

Arlin ZA, Feldman EJ, Finger L, Ahmed T, Mittelman A, Puccio C, Cook P, Chun HG. Arlin ZA, et al. Among authors: chun hg. Semin Hematol. 1991 Jul;28(3 Suppl 4):44-7. Semin Hematol. 1991. PMID: 1780752 Review. No abstract available.

3

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.

Arlin ZA, Feldman EJ, Mittelman A, Ahmed T, Puccio C, Chun HG, Cook P, Baskind P, Marboe C, Mehta R. Arlin ZA, et al. Among authors: chun hg. Cancer. 1991 Sep 15;68(6):1198-200. doi: 10.1002/1097-0142(19910915)68:6<1198::aid-cncr2820680603>3.0.co;2-e. Cancer. 1991. PMID: 1873770

4

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.

Razis E, Arlin ZA, Ahmed T, Feldman EJ, Puccio C, Cook P, Chun HG, Helson L, Mittelman A. Razis E, et al. Among authors: chun hg. Acta Haematol. 1994;91(4):171-4. doi: 10.1159/000204328. Acta Haematol. 1994. PMID: 7976113

5

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

6

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

7

High-dose chemotherapy with autologous stem cell rescue in stage IIIB inflammatory breast cancer.

Yalamanchili K, Lalmuanpuii J, Waheed F, Farjami S, Kancherla R, Qureshi Z, Hoang A, Khaled Y, Lake D, Puccio C, Chun HG, Seiter K, Ahmed T. Yalamanchili K, et al. Among authors: chun hg. Anticancer Res. 2008 Sep-Oct;28(5B):3139-42. Anticancer Res. 2008. PMID: 19031971 Free article.

8

High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome.

Ahmed T, Kancherla R, Qureshi Z, Mittelman A, Seiter K, Mannancheril A, Puccio C, Chun HG, Bar M, Lipshutz M, Ali MF, Goldberg R, Preti R, Lake D, Durrani H, Farley T. Ahmed T, et al. Among authors: chun hg. Bone Marrow Transplant. 2000 May;25(10):1041-5. doi: 10.1038/sj.bmt.1702374. Bone Marrow Transplant. 2000. PMID: 10828863

9

Improving the "quality of remission induction" therapy: a necessary step for increasing the cure rate in acute myelogenous leukemia.

Arlin ZA, Feldman E, Finger L, Decter J, Cook P, Ahmed T, Puccio C, Chun H, Mittelman A. Arlin ZA, et al. Cancer Invest. 1992;10(2):183-4. doi: 10.3109/07357909209032779. Cancer Invest. 1992. PMID: 1551027 Review. No abstract available.

10

Humoral antimelanoma immunity: induction by mouse antiidiotypic mAb, MK2-23 and association with survival of patients with advanced melanoma.

Mittelman A, Puccio C, Chun H, Ahmed T. Mittelman A, et al. Mt Sinai J Med. 1992 May;59(3):234-7. Mt Sinai J Med. 1992. PMID: 1603113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters